首页|环泊酚复合瑞芬太尼用于学龄期儿童无痛胃镜检查镇静的半数有效剂量

环泊酚复合瑞芬太尼用于学龄期儿童无痛胃镜检查镇静的半数有效剂量

扫码查看
目的 探索环泊酚复合瑞芬太尼用于学龄期儿童无痛胃镜检查镇静的半数有效剂量(ED50)。方法 选择行无痛胃镜检查的学龄期儿童,性别不限,年龄6~12岁。静脉注射瑞芬太尼0。5 μg·kg-1后,给予患儿环泊酚(初始剂量0。5 mg·kg-1,依据序贯法确定下一例患儿剂量,镇静成功递减0。05 mg·kg-1,镇静失败递增0。05 mg·kg-1)静脉注射。采用Probit法计算环泊酚的ED50、95%有效剂量(ED95)及其95%置信区间(95%CI)。观察并记录患儿镇静前(T0)、瑞芬太尼给药后(T1)、环泊酚给药后(T2)的平均动脉压(MAP)、心率(HR)、呼吸频率(RR)等生命体征指标,以及检查中不良反应的发生情况。结果 复合瑞芬太尼0。5 μg·kg-1时,环泊酚用于学龄期儿童无痛胃镜检查镇静的 ED50为 0。302 mg·kg-1(95%CI:0。184~0。356 mg·kg-1),ED95 为 0。461 mg·kg-1(95%CI:0。390~1。004 mg·kg-1)。与 T0 比较,患儿 T1、T2 的 MAP、HR、RR 均显著下降(P<0。05),且 T2 的 MAP 显著低于T1(P<0。05)。检查中出现低血压6例,心动过缓5例,呼吸抑制5例(其中3例为短暂性呼吸暂停),无注射痛和胸壁僵硬。结论 环泊酚复合瑞芬太尼0。5 μg·kg-1用于学龄期儿童无痛胃镜检查镇静的ED50为0。302 mg·kg-1(95%CI:0。184~0。356 mg·kg-1),ED95 为 0。461 mg·kg-1(95%CI:0。390~1。004 mg·kg-1)。
Median effective dose of ciprofol combined with remifentanil for sedation in painless gastroscopy of school-aged children
AIM To explore the median effective dose(ED50)of ciprofol combined with remifentanil for sedation in painless gastroscopy of school-aged children.METHODS School-aged children scheduled for painless gastroscopy were selected,regardless of gender,aged 6-12 years old.Following the intravenous injection of remifentanil 0.5 μg·kg-1,the pediatric patient was administered with ciprofol(starting with an initial dose of 0.5 mg·kg-1,the dose for the next child was determined using the Dixon sequential method,based on the sedation situation.A decrease of 0.05 mg·kg-1 was applied for successful sedation,while an increase of 0.05 mg·kg-1 was applied for failed sedation).The ED50,95%effective dose(ED95)and corresponding 95%confidence interval(CI)of ciprofol were calculated by Probit method.The mean arterial pressure(MAP),heart rate(HR),and respiratory rate(RR)of the pediatric patients before sedation(T0),after remifentanil administration(T1),and after ciprofol administration(T2),as well as the occurrence of adverse reactions were recorded.RESULTS The ED50 of ciprofol when combined with 0.5 μg·kg-1 remifentanil in anesthesia induction for school-aged children in painless gastroscopy was 0.302 mg·kg-1(95%CI:0.184 to 0.356 mg·kg-1),and the ED95 was 0.461 mg·kg-1(95%CI:0.390 to 1.004 mg·kg-1).Compared with those at T0,the MAP,HR,and RR of the children decreased significantly at T1 and T2(P<0.05).Compared with those at T1,only MAP decreased significantly at T2(P<0.05).During the examination,there were 6 cases of hypotension,5 cases of bradycardia,and 5 cases of respiratory depression(including 3 cases of transient apnea),with no injection pain or chest wall rigidity.CONCLUSION The ED50 of ciprofol combined with 0.5 μg·kg-1 remifentanil for sedation in painless gastroscopy of school-aged children was 0.302 mg·kg-1(95%CI:0.184 to 0.356 mg·kg-1),and the ED95 was 0.461 mg·kg-1(95%CI:0.390 to 1.004 mg·kg-1).

ciprofolremifentanilchildgastroscopesmedian effective dose

张旭、周加慧、张蓓、宋海成、任悦义

展开 >

青岛大学附属妇女儿童医院 麻醉中心,山东青岛 266011

青岛大学附属妇女儿童医院 内镜中心,山东青岛 266011

环泊酚 瑞芬太尼 儿童 胃镜 半数有效剂量

山东省医学会舒适化医疗-麻醉优化专项资金

YXH2021ZX012

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(6)
  • 15